Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
| Data(s) |
2014
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_6FD3B35B8A79 isbn:0091-6749, 1097-6825 (Electronic) pmid:24797422 doi:10.1016/j.jaci.2014.04.001 isiid:000338930300036 |
| Idioma(s) |
en |
| Fonte |
Journal of Allergy and Clinical Immunology, vol. 134, no. 1, pp. 239-240.e13 |
| Palavras-Chave | #Adult; Antigens, Plant/chemistry; Antigens, Plant/immunology; Asthma/immunology; Asthma/therapy; Conjunctivitis, Allergic/immunology; Conjunctivitis, Allergic/therapy; Desensitization, Immunologic/methods; Female; Humans; Immunization Schedule; Immunoglobulin E/blood; Immunoglobulin G/blood; Immunologic Memory; Injections, Subcutaneous; Middle Aged; Peptides/administration & dosage; Peptides/adverse effects; Rhinitis, Allergic/immunology; Rhinitis, Allergic/therapy |
| Tipo |
info:eu-repo/semantics/article article |
